This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ lamivudine,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. HIV/AIDS: Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that is commonly used as part of combination antiretroviral therapy (ART) for the treatment of HIV infection. It works by inhibiting the activity of reverse transcriptase, an enzyme necessary for the replication of the HIV virus. By reducing viral replication, lamivudine helps to control HIV infection, improve immune function, and prevent the progression to AIDS. It is often used in combination with other antiretroviral drugs to achieve optimal treatment outcomes and reduce the risk of developing drug resistance.

  2. Hepatitis B Virus (HBV) Infection: Lamivudine is also approved for the treatment of chronic hepatitis B virus infection. It works by inhibiting the reverse transcriptase enzyme of HBV, thereby reducing viral replication and slowing down the progression of liver disease. Lamivudine therapy can help improve liver function tests, reduce inflammation and liver damage, and lower the risk of developing complications such as cirrhosis and liver cancer. However, prolonged use of lamivudine in HBV infection may lead to the development of drug-resistant strains of the virus, necessitating careful monitoring and possible adjustment of treatment regimens.

  3. Combination Therapy: Lamivudine is often used in combination with other antiretroviral or antiviral medications to enhance treatment efficacy and reduce the risk of drug resistance. Common combinations include lamivudine with zidovudine (Combivir) or tenofovir (Truvada) for HIV infection, and lamivudine with other antiviral agents for HBV infection.

  4. Prevention of Mother-to-Child Transmission: Lamivudine is sometimes used as part of antiretroviral regimens to prevent mother-to-child transmission of HIV during pregnancy, childbirth, and breastfeeding. By reducing maternal viral load, lamivudine therapy can significantly decrease the risk of HIV transmission to the newborn.

  5. Off-Label Uses: In addition to its approved indications, lamivudine may be used off-label in certain situations, such as in the treatment of HIV infection in pediatric patients, or as part of salvage therapy for individuals with multidrug-resistant HIV or HBV infection. Off-label use should be carefully considered and monitored by healthcare providers, taking into account factors such as drug efficacy, safety, and potential drug interactions.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of lamivudine,(prescription) On Probiotics

Bacteria Impacted by lamivudine,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

Impact of lamivudine,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]